Back to top
more

Amgen (AMGN)

(Delayed Data from NSDQ)

$319.66 USD

319.66
1,467,828

+2.18 (0.69%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $319.25 -0.41 (-0.13%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (83 out of 252)

Industry: Medical - Biomedical and Genetics

Better trading starts here.

Zacks News

Amgen (AMGN) Gains But Lags Market: What You Should Know

Amgen (AMGN) closed the most recent trading day at $235.42, moving +0.26% from the previous trading session.

Mirati (MRTX) Down 7% on CHMP's Opinion on Krazati Filing

Per the CHMP, Mirati's (MRTX) regulatory filing for Krazati in KRASG12C mutated NSCLC does not fulfill certain requirements to support a conditional marketing authorization.

Horizon's (HZNP) Daxdilimab Fails to Meet Goal in Lupus Study

Horizon (HZNP) fails to meet the primary endpoint in the mid-stage study of evaluating daxdilimab in the treatment of systemic lupus erythematosus.

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Smart Beta ETF report for IBB

Should You Invest in the iShares Biotechnology ETF (IBB)?

Sector ETF report for IBB

Amgen (AMGN) Gains But Lags Market: What You Should Know

In the latest trading session, Amgen (AMGN) closed at $227.84, marking a +0.18% move from the previous day.

Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know

Amgen (AMGN) closed the most recent trading day at $227.66, moving +0.88% from the previous trading session.

Yashwardhan Jain headshot

Is Now the Right Time to Embrace Biotech ETFs?

Look if it's the right time to invest in biotech ETFs to help diversify your portfolio.

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.

Amgen (AMGN) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Amgen (AMGN) closed at $218.65, marking a -1.94% move from the previous day.

The Zacks Analyst Blog Highlights Apple, Verizon Communications, Amgen, Charles Schwab and The Cigna Group

Apple, Verizon Communications, Amgen, Charles Schwab and The Cigna Group are part of the Zacks top Analyst Blog.

Sheraz Mian headshot

Top Analyst Reports for Apple, Verizon & Amgen

Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Verizon Communications Inc. (VZ) and Amgen Inc. (AMGN).

Amgen (AMGN) Gains But Lags Market: What You Should Know

In the latest trading session, Amgen (AMGN) closed at $222.02, marking a +0.39% move from the previous day.

Amgen (AMGN) Dips More Than Broader Markets: What You Should Know

Amgen (AMGN) closed the most recent trading day at $227.11, moving -1.11% from the previous trading session.

Horizon's (HZNP) Tepezza Study in Japan for TED Meets Goal

Horizon (HZNP) announces positive top-line results from its phase III study evaluating Tepezza for treating Thyroid Eye Disease with high disease activity in Japan.

Amgen's (AMGN) Blincyto sBLA Gets FDA Nod in Treating Leukemia

Amgen (AMGN) announces full approval of its sBLA for Blincyto as an immune-oncology therapy for treating adults and pediatric patients with CD19-positive B-cell precursor acute lymphoblastic leukemia.

Amgen (AMGN) Gains As Market Dips: What You Should Know

In the latest trading session, Amgen (AMGN) closed at $229.66, marking a +0.53% move from the previous day.

AbbVie's (ABBV) Skyrizi Meets Ulcerative Colitis Study Goals

AbbVie's (ABBV) Skyrizi achieves statistical significance with its primary endpoint of clinical remission in a late-stage study as a maintenance treatment for ulcerative colitis.

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know

Amgen (AMGN) closed at $218.82 in the latest trading session, marking a -0.88% move from the prior day.

The Zacks Analyst Blog Highlights JPMorgan Chase, McDonald's, Comcast, T-Mobile US and Amgen

JPMorgan Chase, McDonald's, Comcast, T-Mobile US and Amgen are part of the Zacks top Analyst Blog.

Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Smart Beta ETF report for PBE

Sheraz Mian headshot

Top Analyst Reports for JPMorgan Chase, McDonald's & Comcast

Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), McDonald's Corporation (MCD) and Comcast Corporation (CMCSA).

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.